
Receca100 mg
NIPRO JMI Pharma Ltd.
Racecadotril is indicated for the symptomatic treatment of acute diarrhea in adults and infants/children (from about 3 months of age), used as an adjunct to oral rehydration therapy (ORT) and more.
Racecadotril is indicated for the symptomatic treatment of acute diarrhea in adults and infants/children (from about 3 months of age), used as an adjunct to oral rehydration therapy (ORT), which remains the essential primary treatment for fluid and electrolyte loss.
Dosage of Racecadotril is individualized by age and body weight, and it is always used alongside adequate oral rehydration. See Dosage and Administration below for details.
Treatment with Racecadotril should generally continue only until diarrhea resolves (see Duration of Treatment), and it should not replace rehydration therapy.
Racecadotril is generally well tolerated. Because it does not slow intestinal motility, it is not typically associated with the constipation or abdominal distension seen with opioid-based antidiarrheals.
Patients should stop Racecadotril and seek urgent medical care if signs of a severe allergic reaction develop.
Racecadotril is contraindicated in patients with known hypersensitivity to racecadotril or to any excipient of the formulation used.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.